| Converging intracranial markers of conscious access R Gaillard, S Dehaene, C Adam, S Clémenceau, D Hasboun, M Baulac, ... PLoS biology 7 (3), e1000061, 2009 | 478 | 2009 |
| Direct intracranial, FMRI, and lesion evidence for the causal role of left inferotemporal cortex in reading R Gaillard, L Naccache, P Pinel, S Clémenceau, E Volle, D Hasboun, ... Neuron 50 (2), 191-204, 2006 | 433 | 2006 |
| Pure alexia as a disconnection syndrome: new diffusion imaging evidence for an old concept S Epelbaum, P Pinel, R Gaillard, C Delmaire, M Perrin, S Dupont, ... cortex 44 (8), 962-974, 2008 | 294 | 2008 |
| A direct intracranial record of emotions evoked by subliminal words L Naccache, R Gaillard, C Adam, D Hasboun, S Clémenceau, M Baulac, ... Proceedings of the National Academy of Sciences 102 (21), 7713-7717, 2005 | 261 | 2005 |
| Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review A Chevance, D Gourion, N Hoertel, PM Llorca, P Thomas, R Bocher, ... L'encephale 46 (3), 193-201, 2020 | 235 | 2020 |
| Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind … M Fedgchin, M Trivedi, EJ Daly, R Melkote, R Lane, P Lim, D Vitagliano, ... International Journal of Neuropsychopharmacology 22 (10), 616-630, 2019 | 206 | 2019 |
| Nonconscious semantic processing of emotional words modulates conscious access R Gaillard, A Del Cul, L Naccache, F Vinckier, L Cohen, S Dehaene Proceedings of the National Academy of Sciences 103 (19), 7524-7529, 2006 | 192 | 2006 |
| Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression—TRANSFORM-3 R Ochs-Ross, EJ Daly, Y Zhang, R Lane, P Lim, RL Morrison, D Hough, ... The American Journal of Geriatric Psychiatry 28 (2), 121-141, 2020 | 124 | 2020 |
| Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study O Lortholary, MO Chandesris, CB Livideanu, C Paul, G Guillet, E Jassem, ... The Lancet 389 (10069), 612-620, 2017 | 94 | 2017 |
| Cortex morphology in first-episode psychosis patients with neurological soft signs O Gay, M Plaze, C Oppenheim, S Mouchet-Mages, R Gaillard, JP Olié, ... Schizophrenia bulletin 39 (4), 820-829, 2013 | 94 | 2013 |
| Auditory mismatch negativity is a good predictor of awakening in comatose patients: a fast and reliable procedure. L Naccache, L Puybasset, R Gaillard, E Serve, JC Willer Clinical neurophysiology: official journal of the International Federation …, 2004 | 90 | 2004 |
| Salivary cortisol in early psychosis: new findings and meta-analysis B Chaumette, O Kebir, C Mam-Lam-Fook, Y Morvan, J Bourgin, BP Godsil, ... Psychoneuroendocrinology 63, 262-270, 2016 | 87 | 2016 |
| Salvage debridement, antibiotics and implant retention (“DAIR”) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with … T Ferry, G Leboucher, C Fevre, Y Herry, A Conrad, J Josse, C Batailler, ... Open forum infectious diseases 5 (11), ofy269, 2018 | 80 | 2018 |
| Brain activations during letter-by-letter reading: A follow-up study C Henry, R Gaillard, E Volle, J Chiras, S Ferrieux, S Dehaene, L Cohen Neuropsychologia 43 (14), 1983-1989, 2005 | 79 | 2005 |
| Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis S Georgin-Lavialle, DS Moura, A Salvador, JC Chauvet-Gelinier, ... Molecular psychiatry 21 (11), 1511-1516, 2016 | 77 | 2016 |
| Cognitive dysfunction in major depressive disorder. A translational review in animal models of the disease F Darcet, AM Gardier, R Gaillard, DJ David, JP Guilloux Pharmaceuticals 9 (1), 9, 2016 | 74 | 2016 |
| A specific role for serotonin in overcoming effort cost F Meyniel, GM Goodwin, JFW Deakin, C Klinge, C MacFadyen, H Milligan, ... Elife 5, e17282, 2016 | 71 | 2016 |
| Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression DS Moura, S Sultan, S Georgin-Lavialle, S Barete, O Lortholary, ... PLoS One 7 (6), e39468, 2012 | 70 | 2012 |
| Repurposing chlorpromazine to treat COVID-19: The reCoVery study M Plaze, D Attali, AC Petit, M Blatzer, E Simon-Loriere, F Vinckier, ... L'encephale 46 (3), 169-172, 2020 | 68 | 2020 |
| Phenotypic continuum between autism and schizophrenia: Evidence from the Movie for the Assessment of Social Cognition (MASC) G Martinez, C Alexandre, C Mam-Lam-Fook, N Bendjemaa, R Gaillard, ... Schizophrenia research 185, 161-166, 2017 | 66 | 2017 |
